Jump to content
IndiaDivine.org

New Treatment Test For Alzheimer's Disease From Lilly

Rate this topic


Guest guest

Recommended Posts

Guest guest

Eli Lilly and Company (NYSE: LLY) has announced today the start of a

Phase III clinical trial studying LY450139, an investigational gamma

secretase inhibitor for the treatment of mild to moderate Alzheimer's

disease. LY450139 is being tested to see if it can ...Read more at

http://healtnhappyness.blogspot.com/

<http://healtnhappyness.blogspot.com/>

 

 

 

 

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...